Hematology and Oncology Disease

Clinical characteristics of intestinal thrombotic microangiopathosis associated with allogeneic hematopoietic stem cell transplantation in children

  • Yanfei CHEN ,
  • Xuemei ZHONG ,
  • Xin MA ,
  • Weiwei LIAO ,
  • Rong LIU ,
  • Jizhen ZOU
Expand
  • Children's Hospital Capital Institute of Pediatrics, Beijing 100020, China

Received date: 2021-08-25

  Online published: 2023-03-10

Abstract

Objective To explore the clinicopathological features and treatment of intestinal thrombotic microangiopathopathy (iTMA) associated with allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children, and to provide reference for the early diagnosis and treatment of iTMA. Methods The clinical data of 3 children with iTMA after allo-HSCT treatment were retrospectively analyzed. Results All three patients developed gastrointestinal symptoms such as abdominal pain, intractable diarrhea or severe hematochezia 20 to 50 days after allo-HSCT. Gastroscopy showed different degrees of mucosal bleeding. Colonoscopy showed active or old bleeding, brittle mucous membrane and some erosion. Pathological examination revealed different degrees of mucosal lamina propria disappearance, atypical hyperplasia or absence of glands, and microthrombosis. Virus inclusion bodies were seen in 1 child. Combined with clinical symptoms, iTMA was considered in all the children. After the withdrawal of calcineurin inhibitor and symptomatic treatment, the symptoms of 2 children were relieved in about 2 weeks. After 20 days of stopping the use of calcineurin inhibitors and adding mycophenolate combined with methylprednisolone, plasma exchange, and deinoside, the clinical symptoms of one patient gradually improved. Conclusions iTMA is a complication of allo-HSCT in children and may be associated with graft-versus-host disease (GVHD) and cytomegalovirus infection. For children with severe refractory diarrhea after allo-HSCT, the differential diagnosis of iTMA, GVHD and cytomegalovirus infection should be made by gastrointestinal endoscopy and biopsy pathology as soon as possible, so as to help clinical timely modification of treatment strategies.

Cite this article

Yanfei CHEN , Xuemei ZHONG , Xin MA , Weiwei LIAO , Rong LIU , Jizhen ZOU . Clinical characteristics of intestinal thrombotic microangiopathosis associated with allogeneic hematopoietic stem cell transplantation in children[J]. Journal of Clinical Pediatrics, 2023 , 41(3) : 192 -196 . DOI: 10.12372/jcp.2023.21e1226

References

[1] Rosentha J. Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment[J]. J Blood Med, 2016, 7: 181-186.
[2] Warren M, Jodele S, Dandoy C, et al. A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy[J]. Arch Pathol Lab Med, 2017, 141(11): 1558-1566.
[3] 董陆佳, 谢大鹤, 陆道培, 等. 造血干细胞移植相关性肠道血栓性微血管病临床病理学特征、诊断标准和治疗[J]. 中国实验血液学杂志, 2006, 14(2): 327-331.
[4] El-Bietar J, Warren M, Dandoy C, et al. Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2015, 21(11): 1994-2001.
[5] Seaby EG, Gilbert RD. Thrombotic microangiophathy following haematopoietic stem cell transplant[J]. Pediatr Nephrol, 2018, 33: 1489-1500.
[6] Young JA, Pallas CR, Knovich MA. Transplant-associated thrombotic microangiopathy: theoretical cosiderations and a practical approach to an unrefined diagnosis[J]. Bone Marrow Transplant, 2021, 56(8): 1805-1817.
[7] Li A, Wu Q, Davis C, et al. Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal[J]. Biol Blood Marrow Transplant, 2019, 25(3): 570-576.
[8] Thomas W, Foukaneli T, Cosgrove J, et al. Transplant-associated thrombotic microangiopathy and immune haematological complications following intestine-containing organ transplantation: experience from over 100 consecutive cases[J]. Br J Haematol, 2021, 193(5): 961-970.
[9] Jodele S, Dandoy CE, Lane A, et al. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab[J]. Blood, 2020, 135(13): 1049-1057.
[10] 杨丽萍, 刘晓, 张晓辉. 造血干细胞移植相关血栓性微血管病的诊疗进展[J]. 中华血液学杂志, 2021, 42(8): 693-699.
[11] Jodele S, Dandoy CE, Myers KC, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy[J]. Transfus Apher Sci, 2016, 54(2): 181-190.
[12] Jodele S, Laskin BL, Dandoy CE, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury[J]. Blood Rev, 2015, 29(3): 191-204.
[13] Warren M, Jodele S, Dandoy C, et al. A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy[J]. Arch Pathol Lab Med, 2017, 141(11): 1558-1566.
[14] 刘婉莹, 肖毅. 异基因造血干细胞移植后血栓性微血管病的诊治进展[J]. 中华器官移植, 2021, 42(8): 509-512.
[15] Nishida T, Hamaguchi M, Hirabayashi N, et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease[J]. Bone Marrow Transplant, 2004, 33(11): 1143-1150.
[16] El-Bietar J, Warren M, Dandoy C, et al. Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2015, 21(11): 1994-2001.
[17] Dvorak CC, Higham C, Shimano KA. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management[J]. Front Pediatr, 2019, 7: 133.
[18] Jia C, Qin M, Wang B, et al. Variable clinical manifestations of hematopoietic stem cell transplant-associated thrombotic microangiopathy[J]. Pediatr Investig, 2019, 2(4): 253-256.
[19] Schoettler M, Lehmann L, Li A, et al. Thrombotic microangiopathy following pediatric autologous hematopoietic cell transplantation: a report of significant end-organ dysfunction in eculizumab-treated survivors[J]. Biol Blood Marrow Transplant, 2019, 25(5): e163-e168.
Outlines

/